Translations:Metformin/39/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
Tags: Mobile edit Mobile web edit
 
(No difference)

Latest revision as of 19:35, 11 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Metformin)
Metformin exerts an anorexiant effect in most people, decreasing caloric intake. Metformin decreases [[gluconeogenesis]] (glucose production) in the liver. Metformin inhibits basal secretion from the [[pituitary gland]] of [[growth hormone]], [[adrenocorticotropic hormone]], [[follicle stimulating hormone]], and expression of [[proopiomelanocortin]], which in part accounts for its insulin-sensitizing effect with multiple actions on tissues including the liver, skeletal muscle, endothelium, adipose tissue, and the ovaries. The average patient with type{{nbsp}}2 diabetes has three times the normal rate of gluconeogenesis; metformin treatment reduces this by over one-third.

Metformin exerts an anorexiant effect in most people, decreasing caloric intake. Metformin decreases gluconeogenesis (glucose production) in the liver. Metformin inhibits basal secretion from the pituitary gland of growth hormone, adrenocorticotropic hormone, follicle stimulating hormone, and expression of proopiomelanocortin, which in part accounts for its insulin-sensitizing effect with multiple actions on tissues including the liver, skeletal muscle, endothelium, adipose tissue, and the ovaries. The average patient with type 2 diabetes has three times the normal rate of gluconeogenesis; metformin treatment reduces this by over one-third.